The 10-year OS rate exhibited an upward trend but did not reach statistical significance in the IM+HR group compared to the IM group and IM+RFA/TACE group (93.3% vs 63.0% vs 55.2%, P =0.187, Fig. 4 A).
← all excerpts
The long-term efficacy of imatinib with hepatic resection or other local treatment for gastrointestinal stromal tumours liver metastases: a retrospective cohort study.
1
0.1870
0.1870